HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G: Sales Growth Strongest When Rising Tide Floats All Competitors Across All Categories

Executive Summary

P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.

You may also be interested in...



Crest Charcoal Toothpaste Claims Mislead Consumers – Class Action Complaint

“In recent years, health and beauty products containing activated charcoal have become a consumer sensation,” and P&G/Crest has sought to capitalize on demand with falsely advertised charcoal toothpaste offerings, according to plaintiff Belinda Housey’s class action complaint in New York’s Southern District.

P&G Health, Hygiene Brands Ride Consumer ‘Trust’ To Sales Growth Amid Pandemic Uncertainty

“There’s a heightened need for products that deliver against health, hygiene and clean home concerns and a willingness to spend just a little bit more to ensure that I’m using a product that I know and trust,” says CFO Jon Moeller 

P&G In COVID And Beyond: ‘We Will Serve A Forever-Altered Health, Hygiene And Cleaning Focus’

After reporting 6% organic growth for fiscal 2020, ended on 30 June, P&G’s increasingly health, hygiene and cleaning-focused business is still going strong, CFO Jon Moeller said at the Barclays Global Consumer Staples Conference. While uncertainties abound, P&G remains confident in its strategy, portfolio and long-term prospects.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150767

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel